A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancrea... von Stathopoulos, G P, Syrigos, K, Aravantinos, G, Polyzos, A, Papakotoulas, P, Fountzilas, G, Potamianou, A, Ziras, N, Boukovinas, J, Varthalitis, J, Androulakis, N, Kotsakis, A, Samonis, G, Georgoulias, V

Volltext

CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma von PECTASIDES, D, MYLONAKIS, A, KOSTOPOULOU, M, PAPADOPOULOU, M, TRIANTAFILLIS, D, VARTHALITIS, J, DIMITRIADES, M, ATHANASSIOU, A

Volltext

TPA, TATI, CEA, AFP, β-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder von PECTASIDES, D, BAFALOUCOS, D, ANTONIOU, F, GOGOU, L, ECONOMIDES, N, VARTHALITIS, J, DIMITRIADES, M, KOSMIDIS, P, ATHANASSIOU, A

Volltext

Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide von PECTASIDES, D, MOUTZOURIDES, G, DIMITRIADIS, M, VARTHALITIS, J, ATHANASSIOU, A

Volltext

An Outpatient Phase II Study of Subcutaneous Interleukin-2 and Interferon-Alpha-2b in Combination with Intravenous Vinblastine in Metastatic Renal Cell Cancer von Pectasides, D., Varthalitis, J., Kostopoulou, M., Mylonakis, A., Triantaphyllis, D., Papadopoulou, M., Dimitriadis, M., Athanassiou, A.

Volltext

Paclitaxel in cisplatin or carboplatin-pretreated ovarian cancer : Phase II study von PECTASIDES, D, PAPADOPOULOU, M, VARTHALITIS, J, MYLONAKIS, A, KOSTOPOULOU, M, DIMITRIADIS, M, ATHANASSIOU, A

Volltext

Chemotherapy with Methotrexate, Carboplatin, Mitoxantrone (Novantrone) and Vincristine (Oncovin) in Transitional-Cell Urothelial Cancer von Pectasides, D., Mylonakis, A., Antoniou, F., Kostopoulou, M., Triantaphyllis, D., Papadopoulou, M., Varthalitis, J., Dimitriadis, M., Athanassiou, A.

Volltext

Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: A multicentre phase II study von Rapti, Ageliki, Agelidou, Athina, Stergiou, Ioannis, Agelidou, Maria, Nikolakopoulos, Ioannis, Varthalitis, John, Kalykaki, Antonia, Chainis, Kyriakos, Tzanakis, Nikolaos, Georgoulias, Vassilis

Volltext

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin von PECTASIDES, D, YIANNIOTIS, H, ALEVIZAKOS, N, BAFALOUKOS, D, BARBOUNIS, V, VARTHALITIS, J, DIMITRIADIS, M, ATHANASSIOU, A

Volltext

Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as 1 st line treatment in patients with ovarian cancer: A multicenter phase II clinical trial von Potamianou, A., Polyzos, A., Boukovinas, J., Latoufis, C., Andoulakis, N., Agelidou, S., Kotsakis, A., Giassas, S., Varthalitis, J., Vamvakas, L.

Volltext

Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as 1 st line treatment in patients with ovarian cancer: A multicenter phase II clinical trial von Potamianou, A., Polyzos, A., Boukovinas, J., Latoufis, C., Andoulakis, N., Agelidou, S., Kotsakis, A., Giassas, S., Varthalitis, J., Vamvakas, L.

Volltext

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer von Agelaki, Sofia, Syrigos, Kostas, Christophylakis, Charalambos, Boukovinas, John, Varthalitis, John, Pavlakou, Georgia, Athanasiadis, Athanasios, Kouroussis, Charalambos, Vardakis, Nikolaos, Maltezakis, George, Milaki, Georgia, Georgoulias, Vassilis

Volltext

Docetaxel in combination with gemcitabine (DG) versus docetaxel (D) as front-line treatment in patients with advanced/metastatic NSCLC: A multicentre, randomized, phase III trial von Georgoulias, V., Syrigos, K., Agelidou, M., Potamianou, A., Polyzos, A., Varthalitis, J., Gerogianni, A., Ziras, N., Mavroudis, D., Androulakis, N., Samonis, G.

Volltext

Paclitaxel in Cisplatin or Carboplatin-Pretreated Ovarian Cancer von Pectasides, D., Papadopoulou, M., Varthalitis, J., Mylonakis, A., Kostopoulou, M., Dimitriadis, M., Athanassiou, A.

Volltext

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin: Clinical Oncology/Epidemiology von Pectasides, D, Yianniotis, H, Alevizakos, N, Bafaloukos, D, Barbounis, V, Varthalitis, J, Dimitriadis, M, Athanassiou, A

Volltext

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab von Koutras, A K, Antonacopoulou, A G, Eleftheraki, A G, Dimitrakopoulos, F-I, Koumarianou, A, Varthalitis, I, Fostira, F, Sgouros, J, Briasoulis, E, Bournakis, E, Bafaloukos, D, Bompolaki, I, Galani, E, Kalogeras, K T, Pectasides, D, Fountzilas, G, Kalofonos, H P

Volltext

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) von Chang, A., Manegold, C., Douillard, J.-Y., Malik, R., Giaccone, G., Begbie, S., Jennens, R., Tzekova, V., Couture, F., Hirsh, V., Burkes, R., Sangha, R., Ambrus, M., Janaskova, T., Musil, J., Jakesova, J., Roubec, J., Vanasek, J., Barlesi, F., Bennouna-Louridi, J., Chouaid, C., Robinet, G., Souquet, P.-J., Spaeth, D., Schott, R., Lena, H., Baize, N., Molinier, O., Fuchs, F., Marschner, N., Schuette, W., Syrigos, K., Papandreou, C., Bocskei, C., Juhasz, E., Losonczy, G., Mark, Z., Molnar, I., Papai-Szekely, Z., Tehenes, S., Vinkler, I., Maru, A., Pathak, A., Prasad, S.V.S.S., Kilara, N., Gorijavolu, D., John, S., Amoroso, D., Bajetta, E., Bonetti, A., Maio, M., Passalacqua, R., Bitina, M., Brize, A., Purkalne, G., Skrodele, M., Samson-Fernando, M.C., Jassem, J., Koralewski, P., Cebotaru, C., Ganea-Motan, D.E., Ianuli, C.H., Manolescu, I.G., Udrea, A., Burdaeva, O., Filippov, A., Lazarev, S., Tan, Y.O., Bastus Piulats, R., Garcia-Foncillas, J., Valdivia, J., de Castro, J., Lee, J.-S., Lee, J.S., Shin, S.W., Kim, Y.-C., Chang, G.-C., Goan, Y.-G., Kuo, H.-P., Demir, G., Crawford, J., Giaccone, G., Agarwal, M., Pandit, S., Araujo, R., Vrindavanam, N., Bonomi, P., Wade, J., Camidge, R., Hill, D., Rarick, M., Flynn, P., Savin, M., Richards, D., Dangoor, A., Summers, Y., Rankin, E., Rowley, K., Kristeleit, H., Taylor, P.

Volltext

Gemcitabine combined with the MTOR Inhibitor Temsirolimus(CCI-779) in Patients with Inoperable or Metastatic Pancreatic Cancer (He 3/07). A Phase I Study by the Hellenic Cooperativ... von Karavasilis, V., Pentheroudakis, G., Sgouros, J., Dimoudis, S.T., Varthalitis, I., Samantas, E., Fountzilas, G.

Volltext

Treatment of advanced malignant eccrine poroma with locoregional chemotherapy von De Bree, E., Volalakis, E., Tsetis, D., Varthalitis, Y., Panagiotidis, J., Romanos, J., Tsiftsis, D.D.

Volltext

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based... von Kakolyris, S., Souglakos, J., Polyzos, A., Ardavanis, A., Ziras, N., Athanasiadis, A., Varthalitis, I., Amarantidis, K., Tsousis, S., Vamvakas, L., Vardakis, N., Georgoulias, V.

Volltext